Skip Navigation

Application Information

Important Update

The Emory Preventive Medicine Residency Program has joined the American College of Preventive Medicine's Standardized Acceptance Process for Resident applications. Please view this document to understand the timeline that we - and the majority of Preventive Medicine Residencies - will be following for this year. 


The Preventive Medicine Residency Program follows the established guidelines set forth by Emory University School of Medicine (SOM), the Accreditation Council for Graduate Medical Education (ACGME), and the Office of Graduate Medical Education (GME) concerning resident eligibility and selection.

All residents appointed to the Preventive Medicine Residency Program of the Emory University School of Medicine must meet the following qualifications to be eligible for a position in the graduate medical education program at Emory.

All prerequisite post-graduate clinical education required for initial entry or transfer into ACGME-accredited residency programs must be completed in ACGME-accredited residency programs, or in Royal College of Physicians and Surgeons of Canada (RCPSC)-accredited or College of Family Physicians of Canada (CFPC)-accredited residency programs located in Canada. Residency programs must receive verification of each applicant’s level of competency in the required clinical field using ACGME or CanMEDS Milestones assessments from the prior training program.

To be eligible for appointment at the Preventive Medicine-1 level, applicants must have successfully completed at least 12 months of clinical education in a residency program accredited by ACGME, RCPSC, or CFPC.

  1. obtaining a comprehensive medical history;
  2. performing a comprehensive physical examination;
  3. assessing a patient’s medical conditions;
  4. making appropriate use of diagnostic studies and tests;
  5. integrating information to develop a differential diagnosis; and
  6. developing, implementing, and evaluating a treatment plan.

To be eligible for appointment at the Preventive Medicine-2 level, residents must have completed:


If you are eligible based on the above requirements, please send ALL application documents to the Program Coordinator in one email. The only documents that can be accepted separately are the letters of recommendation and any official transcripts you request. Otherwise, your application is flagged as incomplete. 

Email complete applications only to: Residency Program Coordinator, Brittany Summerlin, MPH, CHES at 

1. Current CV which should, at the least, include the following information:

2. Personal statement that covers your interest in public health and preventive medicine (including relevant work or experiences), and your career plans or goals as a result of training received in the Emory Preventive Residency Program. Please limit your statement to a maximum of 2 pages; 

3. Certificate(s), letter(s), or verification form(s), attesting to your successful completion of an internship (or preliminary) year, and residency(cies) in a clinical specialty;

4. Official USMLE Step 3 results from all attempts (passage of all is required);

5. Certificate from the Educational Commission for Foreign Medical Graduates (if applicable);

6. Official transcripts from undergraduate, medical, and other graduate schools (unofficial versions may be used as placeholders until the institution sends official copies. You may also forward/scan an official copy);

7. Three letters of recommendation, one of which MUST be from your most recent residency program director. We require residents to waive their rights to view the letters and we request that letters be sent directly from the writer to the Emory Preventive Medicine Program Coordinator (contact information below) from the writer's institutional email address (reference letters sent from personal emails will need to be forwarded from institution accounts before they can be accepted). The letters should, at a minimum, address the following:


Generally, applications are accepted year round, but are actively under review based on the following schedule:

This page was updated on September 30, 2016